BioAro, a pioneer in genomic research and technology, is set to officially launch PanOmiQ, a revolutionary software that will redefine the landscape of genomic analysis globally by providing real-time insights into the complexities of the human genome. With unparalleled speed, precision, and versatility, it promises to transform healthcare worldwide. The Global...
Data is everywhere, but insight is rare. Insights are hidden deep in the data and require tons of work and time to dig out. Knowledge professionals in clinical trials, medical, strategy, and regulatory affairs are struggling with the rapid growth of data — it's everywhere and it's overwhelming. One...
Results from evaluation of the company's SpliceCore® AI/ML platform in Triple Negative Breast Cancer published in Molecular Systems Biology
Envisagenics, an AI-driven biotechnology company, announced the publication in the journal Molecular Systems Biology of study results evaluating the company's SpliceCore AI/ML platform in Triple Negative Breast Cancer (TNBC). This study demonstrates...
Tenured Life Sciences Executive Joins AI-Driven Drug Discovery Company to Provide Strategic Guidance and Support Pipeline Growth
Model Medicines, a leading human health company specializing in generative AI-driven drug discovery, announced the appointment of Dr. Launa Aspeslet as Senior Scientific & Clinical Advisor. In this role, Dr. Aspeslet will provide...
Xaira is an integrated biotechnology company built to deliver on the promise of emerging AI tools to help transform the drug discovery and development process, providing more effective therapies to patients faster.
Xaira Therapeutics launched on a mission to help re-engineer the way we discover and develop medicines through the...
Advancements help neurologists detect and analyze suspected seizure events from patients in home healthcare settings for extended periods of time
Epitel, a leader in AI technologies for patient-focused brain health solutions, announced it received U.S. Food and Drug Administration (FDA) 510(k) clearances for two new innovative technologies: REMI™ Remote EEG...
Advanced Intake™ demonstrates efficiency gains of up to 65% in adverse event recording and 90% accuracy and quality of data extraction
ArisGlobal , an innovative life sciences technology company and developer of LifeSphere®, announced details of its Advanced Intake solution , based on LifeSphere NavaX, the next-generation advanced cognitive computing engine of the...
NyquistAI, formerly known as Nyquist Data, is making a strategic pivot that aligns with our evolution as a company and our commitment to the life sciences sector to help companies in life sciences embark on AI transformation within their organizations.
In the past year, we took a significant step by...
Ochre Bio, a pioneer in chronic liver disease medicine development, announced a partnership with Boehringer Ingelheim focused on the discovery and development of novel, first-in-class regenerative treatments for chronic liver diseases (CLDs), such as late-stage metabolic dysfunction-associated steatohepatitis (MASH) cirrhosis.
Within the partnership, Ochre Bio will utilise its proprietary discovery...
Veracyte, Inc., a leading cancer diagnostics company, announced that a new study published in JCO Precision Oncology shows that, among patients undergoing Active Surveillance (AS) for prostate cancer, the Decipher Prostate Genomic Classifier is prognostic for identifying those whose disease is likely to progress. The findings make the Decipher test...
